These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 16513614)

  • 41. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
    Suzuki K; Li F; Sone S; Doi K
    IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung nodule enhancement at CT: multicenter study.
    Swensen SJ; Viggiano RW; Midthun DE; Müller NL; Sherrick A; Yamashita K; Naidich DP; Patz EF; Hartman TE; Muhm JR; Weaver AL
    Radiology; 2000 Jan; 214(1):73-80. PubMed ID: 10644104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.
    Demir Y; Polack BD; Karaman C; Ozdoğan O; Sürücü E; Ayhan S; Akkoçlu A; Ozdemir N
    Nucl Med Commun; 2014 Mar; 35(3):260-7. PubMed ID: 24468852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
    Lin KH; Lee RC; Liu RS; Chang CY
    Nucl Med Commun; 2016 Apr; 37(4):356-62. PubMed ID: 26796032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
    Jeong SY; Lee KS; Shin KM; Bae YA; Kim BT; Choe BK; Kim TS; Chung MJ
    Lung Cancer; 2008 Aug; 61(2):186-94. PubMed ID: 18280613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.
    Ohno Y; Nishio M; Koyama H; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
    AJR Am J Roentgenol; 2013 Jun; 200(6):W593-602. PubMed ID: 23701089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
    Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A
    J BUON; 2013; 18(4):935-41. PubMed ID: 24344020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
    Sathekge MM; Maes A; Pottel H; Stoltz A; van de Wiele C
    S Afr Med J; 2010 Sep; 100(9):598-601. PubMed ID: 20822650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
    Alkhawaldeh K; Bural G; Kumar R; Alavi A
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):246-52. PubMed ID: 17938921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
    Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
    Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
    Ben-Nun A; Orlovsky M; Best AL; Bar Shalom R
    Harefuah; 2006 Oct; 145(10):713-7, 784, 783. PubMed ID: 17111703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?
    Chundru S; Wong CY; Wu D; Balon H; Palka J; Chang CY; Gaskill M; Cheng CY; Huang WS; Fink-Bennett D
    Nucl Med Commun; 2008 Jul; 29(7):623-7. PubMed ID: 18528184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
    Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dynamic enhanced scanning of the pulmonary nodules with 16-slice spiral CT].
    Li XY; Zhang XL; Zhang YZ; Chen B; Whang JP; Shi Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):133-6. PubMed ID: 19218133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
    Lohrmann C; Weber WA
    Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Contrast-enhanced study of solitary pulmonary nodules with thin-section computed tomography].
    Gaeta M; Volta S; Bartiromo G; Stroscio S; Minutoli F; Barone M
    Radiol Med; 1997 Sep; 94(3):189-92. PubMed ID: 9446123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions.
    Kono R; Fujimoto K; Terasaki H; Müller NL; Kato S; Sadohara J; Hayabuchi N; Takamori S
    AJR Am J Roentgenol; 2007 Jan; 188(1):26-36. PubMed ID: 17179342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.